Comparison of blood-sparing efficacy of ∈-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery

Thoracic and Cardiovascular Surgeon

Volumn 59, Issue 5, 2011, Pages 276-280

  Martin, K ^a   Gertler, R ^a   Sterner, A ^a   MacGuill, M ^a   Schreiber, C ^a   Horer J ^a   Vogt, M ^a   Tassani, P ^a   Wiesner, G ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

blood transfusion (includes blood typing); cardiopulmonary bypass; CHD; congenital heart disease; CPB; neonate

Indexed keywords

AMINOCAPROIC ACID; TRANEXAMIC ACID;

ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HEART SURGERY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; NEWBORN; PEDIATRIC SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION;

6-AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; FEMALE; GERMANY; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; MALE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; TIME FACTORS; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 79961116726     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0030-1250645     Document Type: Article

References (20)

1. Koch C G., Li L, Duncan A I. et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006 34 1608-1616 (Pubitemid 43810038)
2. Kipps A K., Wypij D, Thiagarajan R R., Bacha E A., Newburger J W. Blood transfusion is associated with prolonged duration of mechanical ventilation in infants undergoing reparative cardiac surgery. Pediatr Crit Care Med Epub 2010 May 6
3. Eaton M P. Antifibrinolytic therapy in surgery for congenital heart disease. Anesth Analg 2008 106 1087-1100 (Pubitemid 351450530)
4. Chauhan S, Bisoi A, Modi R, Gharde P, Rajesh M R. Tranexamic acid in paediatric cardiac surgery. Indian J Med Res 2003 118 86-89 (Pubitemid 37493015)
5. Chauhan S, Das S N., Bisoi A, Kale S, Kiran U. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 2004 18 141-143 (Pubitemid 38506857)
6. Chauhan S, Kumar B A., Rao B H. et al. Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. Ann Thorac Surg 2000 70 1308-1312
7. Rao B H., Saxena N, Chauhan S, Bisoi A K., Venugopal P. Epsilon aminocaproic acid in paediatric cardiac surgery to reduce postoperative blood loss. Indian J Med Res 2000 111 57-61 (Pubitemid 30245600)
8. Reid R W., Zimmerman A A., Laussen P C. et al. The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 1997 84 990-996 (Pubitemid 27197656)
9. Levin E, Wu J, Devine D V. et al. Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid. Thromb Haemost 2000 83 54-59 (Pubitemid 30045477)
10. Zonis Z, Seear M, Reichert C, Sett S, Allen C. The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 1996 111 982-987 (Pubitemid 26146052)
11. Bulutcu F S., Ozbek U, Polat B et al. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination? Paediatr Anaesth 2005 15 41-46 (Pubitemid 40188791)
12. Ririe D G., James R L., O'Brien J J. et al. The pharmacokinetics of epsilon-aminocaproic acid in children undergoing surgical repair of congenital heart defects. Anesth Analg 2002 94 44-49 (Pubitemid 34038716)
13. Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 2009 180 183-193
14. Kern F H., Morana N J., Sears J J., Hickey P R. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992 54 541-546
15. Paparella D, Brister S J., Buchanan M R. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004 30 1873-1881 (Pubitemid 39468407)
16. Kuhle S, Male C, Mitchell L. Developmental hemostasis: pro- and anticoagulant systems during childhood. Semin Thromb Hemost 2003 29 329-338
17. Albisetti M. The fibrinolytic system in children. Semin Thromb Hemost 2003 29 339-348
18. Goldschmidt B, Sarkadi B, Gardos G, Matlary A. Platelet production and survival in cyanotic congenital heart disease. Scand J Haematol 1974 13 110-115
19. Gill J C., Wilson A D., Endres-Brooks J, Montgomery R R. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood 1986 67 758-761 (Pubitemid 16130269)
20. McClure P D., Izsak J. The use of epsilon-aminocaproic acid to reduce bleeding during cardiac bypass in children with congenital heart disease. Anesthesiology 1974 40 604-608